TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
---|---|---|---|---|---|---|---|---|---|---|---|
S | %ret | 1 | 1 | 2 | 1 | 1 | 5 | 11 | 38 | 72 | 21 |
S | %wins | 50 | 50 | 0 | 50 | 0 | 0 | 25 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5/22/24 18:17 | 5/20/24 | KRYS | Krystal Biotech, Inc. | Health | BioPrd | Biological Products, (No Diag | Gangolli Julian S | PA | D | S.d | -3,283 | 164.13 | 0 | -20 | -100 | 0 | D | ||||||||||||||||
5/14/19 21:00 | 5/10/19 | GWPH | Gw Pharmaceuticals Plc | Health | Drug | Pharmaceutical Preparations | Gangolli Julian S | X0 | O | P,North | S.d | -9,973 | 14.84 | 0 | -672 | -86 | 107 | D | |||||||||||||||
2/28/19 17:09 | 2/26/19 | GWPH | Gw Pharmaceuticals Plc | Health | Drug | Pharmaceutical Preparations | Gangolli Julian S | X0 | O | P,North | S.d | -75 | 12.45 | 0 | -6 | -5 | 107 | D | |||||||||||||||
12/30/13 17:18 | 12/27/13 | AGN | Allergan Inc | DE | Health | Drug | Pharmaceutical Preparations | Gangolli Julian S | CA | O | CVP,P,No | S.d | -5,778 | 110.05 | 33 | -53 | -67 | 25 | D | 166 | 85 | 31 | 14 | 1 | -1 | 3 | 0 | 1 | 1 | 9 | 24 | 35 | 57 |
11/29/12 19:55 | 11/27/12 | AGN | Allergan Inc | DE | Health | Drug | Pharmaceutical Preparations | Gangolli Julian S | CA | O | CVP,P,No | S.dm | -8,270 | 91.89 | 33 | -90 | -76 | 28 | D | 77 | 37 | 18 | 5 | 0 | 0 | 4 | 1 | 0 | 0 | 1 | -3 | 41 | 87 |
D | Derivative transaction in filing (usually option exercise) |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
A | Amended filing |
E | Error detected in filing |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |